PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40122F19001E014042 FDA enterprise RISK management program — Deloitte Consulting LLP

Deloitte Consulting LLP holds $8.7B across 1,463 federal awards, concentrated at General Services Administration (GSA). This PIID sits alongside 1 related award under parent 75F40121A00003. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs

Awarding office

Deloitte Consulting LLP

Recipient

Sep 29, 2027

PoP end

$111M

Obligated

541611

NAICS

R699

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Deloitte Consulting LLP — $90

Contract facts

NONE

Contract number75F40122F19001

Also listed as75F40121A00003-75F40122F19001

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

IncumbentDeloitte Consulting LLP

UEICKV2L9GZKJK3

NAICS541611

PSCR699

Parent IDIQ / IDV75F40121A00003

Place of performanceBELTSVILLE, MD

Related solicitation1250780

PoP end (current)Sep 29, 2027

PoP end (w/ options)Jan 17, 2028

Obligated$111M

E014042 FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT is a federal NONE award for Fda Office Of Acq Grant Svcs held by Deloitte Consulting LLP. Estimated value $111M ($111M obligated). Current period of performance ends Sep 29, 2027 (potential Jan 17, 2028). Last award drew 1 bidder. Place of performance: BELTSVILLE, MD. Related solicitation 1250780.

E014042 FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT

Recompete timing

Public

● Expiring in 405 days

Current PoP ends Sep 29, 2027 (405 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Incumbent footprint

Public record

Deloitte Consulting LLP — $8.7B obligated across 1,463 awards (firm-wide, all agencies) · lead buyer General Services Administration (GSA).

% of firm-wide obligated ($8.7B) · all agencies · Top 4 shown (66%); remaining ~34% is other agencies.

General Services Administration (GSA)$1.8B · 21%Department of Defense (DOD)$1.7B · 20%Department of Health and Human Services (HHS)$1.3B · 15%Department of Homeland Security (DHS)$938.0M · 11%

Open full company profile →

Related awards

Same parent · incumbent

75F40122F19002

OIMT COST ALLOCATION AND TECHNOLOGY BUSINESS MANAGEMENT

Department of Health and Human Services (HHS) · DELOITTE CONSULTING LLP

$98.1M

Sep 28, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40122F19001?

75F40122F19001 (E014042 FDA enterprise RISK management program) is a Fda Office Of Acq Grant Svcs award with an estimated value of $111M, currently held by Deloitte Consulting LLP. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40122F19001?

Fda Office Of Acq Grant Svcs awarded 75F40122F19001 to Deloitte Consulting LLP.

Who is the incumbent on 75F40122F19001?

Deloitte Consulting LLP is the incumbent with $8.7B across 1463 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2027.

When does Deloitte Consulting LLP’s 75F40122F19001 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Jul 31, 2026